Article
A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
Brain and behavior - 1 May 2024
Li Yao, Chen Ling, Huang Lizhao, Li Xuedong, Huang Qidan, Tang Lifang, Huang Zhiwei, Zhu Li, Li Tao
Abstract excerpt
BACKGROUND AND PURPOSE: As a crucial diagnostic and prognostic biomarker, telomerase reverse transcriptase (TERT) promoter mutation holds immense significance for personalized treatment of patients with glioblastoma (GBM). In this study, we developed a radiomics nomogram to determine the TERT promoter mutation status and assessed its prognostic efficacy in GBM patients. METHODS: The study retrospectively included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.